Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thermosensitivity of Topical Palmitated Capsaicin
NCT05649228Phase 1Completed
- Sponsor
- Carilion Clinic
- Start
- Dec 2022
- Primary completion
- Jan 2024
- Modality
- Transdermal Patches, Hydrogel Systems, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of capsaicin palmitate in Musculoskeletal pain and arthritis (3 arms), sponsored by Carilion Clinic. Primary endpoint: Change in relative burning potential. Started Dec 2022; status: completed.
02
Drugs
capsaicin palmitate
03
Conditions
Musculoskeletal painarthritis
Beyond the preview
Go deeper on NCT05649228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05649228.